通过加权目标编程提高设计后的质量:关于制备超可变形脂质体的案例研究
Sonia Valverde Cabeza1, Pedro Luis González-R2, María Luisa González-Rodríguez1
1Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Universidad de Sevilla, Seville, Spain.
Drug development and industrial pharmacy
|February 24, 2025
概括
权重目标编程 (WGP) 为优化药物配方提供了一种卓越的方法,平衡多个关键属性,如纳米脂质体的尺寸和药物捕获,与设计质量原则保持一致.
科学领域:
- 制药科学 制药科学
- 制定 发展 制定 发展
- 药物输送系统 药物输送系统
背景情况:
- 制药配方需要先进的工具来确保质量,安全性和有效性.
- 设计质量 (QbD) 强调了早期的流程理解和控制.
- 传统的单一目标优化方法对于复杂的配方通常是不够的.
研究的目的:
- 应用权重目标编程 (WGP) 作为一个先进的多目标优化工具.
- 为了优化提摩洛尔 (TM) 装载的纳米脂质体与QbD原则保持一致.
- 为了将WGP与药物配方优化的可取性函数进行比较.
主要方法:
- 一个六步优化过程,包括实验设计 (DOE).
- 定义六个响应的理想/反理想点和愿望水平.
- 应用WGP并与可取性函数进行比较,优先考虑平衡偏差.
主要成果:
- WGP产生了更平衡的纳米脂质体配方,同时优化了多个反应.
- WGP增强了对囊泡大小,体稳定性和药物捕获效率的控制.
- 对比分析证实了WGP在管理冲突目标的有效性,而不过于简化.
结论:
- WGP是一个有价值的先进的多目标优化工具,用于制药应用.
- WGP 改进了复杂药物输送系统的传统方法.
- WGP方法协调了关键属性,支持在QbD下高质量的制药产品开发.
更多相关视频
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...


